诺华公司Novartis AG (NVS) 2004年年度报告「NYSE」.pdf

1、CARING AND CURINGANNUAL REPORT 2004ANNUAL REPORT 2004 Novartis10 000-liter extraction vessel,Novartis pharmaceutical production;Basel,SwitzerlandBack cover:Childrens Hospital Albert Sabin;Fortaleza,Cear,BrazilChildrens Hospital Albert Sabin;Fortaleza,Cear,BrazilNOVARTIS GROUP1OUR MISSIONWe want to d

2、iscover,develop and successfully market innovative products to cure diseases,to ease suffering and to enhance the quality of life.We also want to provide a shareholder return that reflectsoutstanding performance and to adequately reward those who invest ideas and work in our company.2Financial Highl

3、ights3News in 20045Letter from Daniel Vasella10Divisions and Business UnitsPharmaceuticals40Consumer Health50Corporate Citizenship52Commitment to Patients66Commitment to Our People72Commitment to Health,Safety and Environment79Commitment to Business Conduct85Corporate Governance Commitment to Corpor

4、ate Governance104Board of Directors110Executive Committee112Business Unit Heads115Financial Report194Key Dates for 2005195Contact AddressesFront cover:Shanghai Childrens Medical Center,Shanghai Second Medical University;Shanghai,ChinaGROUP OVERVIEWFINANCIAL OVERVIEWNOVARTIS GROUP2Key figures(in USD

5、millions unless indicated otherwise)20042003Net sales28 24724 864Operating income6 5395 889 Net income5 7675 016Return on sales(%)23.123.7Research and development4 2073 756Research and developmentas%of net sales14.915.1Free cash flow3 3593 628Number of employees81 39278 541Net sales by division20042

6、00365%64%35%36%Earnings per share in USD Dividend pay-out ratio in%of net incomeFINANCIAL HIGHLIGHTSPharmaceuticalsConsumer Health20002001200220032004Net sales*Operating income*Net income*in 2000 excluding discontinued Agribusiness DivisionShare information20042003Return on average equity(%)*18.017.